PubMed Health⌕ Search

Biomedical subjects

G Bertocchi

Publications and source records attributed to G Bertocchi.

29 records · Page 2Linked to original sources
PubMed1988

Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.

In women suffering from post-menopausal osteoporosis, we evaluated the effectiveness of two cyclic treatments with synthetic salmon calcitonin over a whole year, using an average daily dose of 16 and 32 IU, respectively. This treatment was compared with treatment with oral calcium carbonate. The results, evaluated by peripheral densitometry of the radius, showed a 3.2% loss of bone mineral content (BMC) in the women treated only with calcium carbonate, a loss of 1% in those treated with an average dose of 16 IU/day of calcitonin and an increase of 4% in the women treated with an average dose of 32 IU/day (an increase just above the statistically significant limit using the paired t-test). An average dose of 32 IU/day probably represents the minimum effective dose of calcitonin required to produce a significant increase in bone mineral mass, when used according to a sequential scheme.

Aged↗
PubMed1987

Synthesis and antimycotic activity of some benzyloxyimino compounds.

Some benzyloxyimio compounds, related to oxiconazole and having a 1H-indole or 1H-benzimidazole moiety, have been synthesized and tested in vitro for their antimycotic activity against Candida tropicalis and C. albicans. The most active was showed to be 0-(2,4-dichlorobenzyl)-1-benzyl-5-nitro-1H-benzimidazole-2-carboxaldehyd e oxime (MIC: 25 micrograms/ml against both microorganisms). A structural feature important for the biological activity of the series appears to be presence of a benzimidazole nucleus substituted by an electron withdrawing group.

Antifungal Agents↗
PubMedDate not supplied

[The X-ray fluorescence (XRF) spectrometry of biomaterials used in dentistry. 2].

In this work we analyze the following biomaterial: biomaterials used in this study are: reabsorbable Dac Blu, non reabsorbable Dac Blu, non reabsorbable atomized Dac Blu, non reabsorbable thin Dac Blu, reabsorbable Biocoral 450, Calcitite 2040-12, Orthogel, Apagen, BTF 65, Calcitite 4060-2, Osprogel, Bio-Oss, Biostite, Osprovit, Merck Hydroxiapatite. The quantitative XRF analysis was performed by a Philips PW 1480 with Rh tube. This research, besides underlining the possibility of applying the XRF method to the analysis of biomaterials. This study, shows the facility and the rapidity in the preparation of samples and standards in the form of tablets to undergo the analysis: furthermore the study shows the possibility of verify the analysis on the same sample in the future, because the tablet if well conserved, does not deteriorate. We can also verify a good analytic accuracy both for the principal elements (Ca, P) and for trace elements. The analyses show a moderate variability in the Ca/P ratio in the hydroxylapatites, and a greater variability in the secondary and trace elements.

Biocompatible Materials↗
PubMedDate not supplied

[The characteristics and properties of calcium phosphates in biomaterial formulations used in dentistry. 1].

In this work we present the features and the properties of natural and synthetic apatites, which we use in an experimental study of various commercial products composed by calcium phosphate. After having considered the general concepts of biomaterials and biocompatibility, we describe non biological tests used for the characterization of these products. Biomaterials used in this study are: reabsorbable Dac Blu, non reabsorbable Dac Blu, non reabsorbable atomized Dac Blu, non reabsorbable thin Dac Blu, reabsorbable Biocoral 450, Calcitite 2040-12, Orthogel, Apagen, BTF 65, Calcitite 4060-2 Osprogel, Bio-oss, Biostite, Osprovit, Merck Hydroxiapatite. Tests used are: X-ray fluorescence (XRF), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), thermogravimetric and thermodifferential analysis (TG, DTG, DTA), scanner-ing electron microscopy (SEM) morphological analysis. Last but not least, we underline the particular features of these tests whose interpretation allows a more precise definition of the bioactivity of a biocompatible material.

Biocompatible Materials↗
PubMedDate not supplied

[The specific characteristics determined by nonbiological tests of mineral-based biomaterials used in dentistry. 7].

In this work we relate about the results coming from crystallographic, physical and mineral tests taken on following biomaterials used in odontostomatology: reabsorbable Dac Blu, non reabsorbable Dac Blu, not reabsorbable atomized Dac Blu, not reabsorbable thin Dac Blu, reabsorbable Biocoral 450, Calcitite 2040-12, Orthogel, Apagen, BTF 65, Calcitite 4060-2, Osprogel, Bio-Oss, Biostite, Osprovit, Merck Hydroxiapatite. The data were obtained using the following tests: XRF, XRD, FTIR, TG, DTG, DTA, SEM. The results, although taken on few samples, showed that these biomaterials present a variability in some features, which can define the structural functionality.

Biocompatible Materials↗